Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10905768 Heterocyclic degronimers for target protein degradation

Patent 10905768 was granted and assigned to C4 Therapeutics on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 18 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 18 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12091397 Dihydroquinolinones for medical treatment
0
Edits on 4 Sep, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 4 Sep, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12076405 Heterocyclic degronimers for target protein degradation
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851445 Compounds and uses thereof
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+333 characters)
Article

Patent abstract

This invention provides heterocyclic compounds that bind to E3 Ubiquitin Ligase (typically through cereblon) (“Degrons”), which can be used as is or linked to a Targeting Ligand for a selected Target Protein for therapeutic purposes and methods of use and compositions thereof as well as methods for their preparation.

Edits on 1 Nov, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 1 Nov, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11802131 Glutarimides for medical treatment
Edits on 19 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11787800 BRD9 degraders and uses thereof
Edits on 5 Oct, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11773085 Methods and compounds for treating disorders
Edits on 27 Sep, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11767330 Citrate salt, pharmaceutical compositions, and methods of making and using the same
Edits on 5 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 5 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11691972 Compounds for targeted degradation of BRD9
0
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=1090576800
Edits on 22 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
C4 Therapeutics
C4 Therapeutics
0
Current Assignee
C4 Therapeutics
C4 Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109057680
Date of Patent
February 2, 2021
0
Patent Application Number
168722250
Date Filed
May 11, 2020
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109057680
Patent Citations
‌
US Patent 10414755 3-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof
0
‌
US Patent 10646575 Heterocyclic degronimers for target protein degradation
0
‌
US Patent 10660968 Spirocyclic degronimers for target protein degradation
0
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
0
‌
US Patent 11524949 Degraders and Degrons for targeted protein degradation
0
‌
US Patent 11560381 Compounds and uses thereof
0
‌
US Patent 11584748 Spirocyclic compounds
0
Patent Primary Examiner
‌
Mark L. Shibuya
0
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 7 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11560381 Compounds and uses thereof
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 3 Apr, 2023
Edits on 1 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 1 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 11584748 Spirocyclic compounds
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Infobox
Patent Citations Received
‌
US Patent 11414416 Compounds and uses thereof
0
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 23 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11584748 Spirocyclic compounds
0
Edits on 25 Jan, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 25 Jan, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11560381 Compounds and uses thereof
0
Edits on 14 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11524949 Degraders and Degrons for targeted protein degradation
0

Find more entities like US Patent 10905768 Heterocyclic degronimers for target protein degradation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo